
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3772322
[patent_doc_number] => 05773606
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Catalyst regeneration'
[patent_app_type] => 1
[patent_app_number] => 8/550707
[patent_app_country] => US
[patent_app_date] => 1995-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3641
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773606.pdf
[firstpage_image] =>[orig_patent_app_number] => 550707
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/550707 | Catalyst regeneration | Oct 30, 1995 | Issued |
Array
(
[id] => 3769399
[patent_doc_number] => 05773420
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation'
[patent_app_type] => 1
[patent_app_number] => 8/531142
[patent_app_country] => US
[patent_app_date] => 1995-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13138
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773420.pdf
[firstpage_image] =>[orig_patent_app_number] => 531142
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/531142 | Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation | Oct 19, 1995 | Issued |
Array
(
[id] => 3827876
[patent_doc_number] => 05760009
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Spirostanyl glycosidal crystalline monohydrate'
[patent_app_type] => 1
[patent_app_number] => 8/532571
[patent_app_country] => US
[patent_app_date] => 1995-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5762
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760009.pdf
[firstpage_image] =>[orig_patent_app_number] => 532571
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/532571 | Spirostanyl glycosidal crystalline monohydrate | Oct 18, 1995 | Issued |
Array
(
[id] => 3933629
[patent_doc_number] => 05929038
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Pharmaceutical preparations which inhibit hepatitis B virus (HBV) replication'
[patent_app_type] => 1
[patent_app_number] => 8/543828
[patent_app_country] => US
[patent_app_date] => 1995-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3917
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929038.pdf
[firstpage_image] =>[orig_patent_app_number] => 543828
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/543828 | Pharmaceutical preparations which inhibit hepatitis B virus (HBV) replication | Oct 15, 1995 | Issued |
Array
(
[id] => 3946014
[patent_doc_number] => 05998380
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Treatment of migraine'
[patent_app_type] => 1
[patent_app_number] => 8/542950
[patent_app_country] => US
[patent_app_date] => 1995-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1915
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998380.pdf
[firstpage_image] =>[orig_patent_app_number] => 542950
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/542950 | Treatment of migraine | Oct 12, 1995 | Issued |
Array
(
[id] => 3897973
[patent_doc_number] => 05750665
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Preparation of glucosaminyl muramic acid derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/539292
[patent_app_country] => US
[patent_app_date] => 1995-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9046
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750665.pdf
[firstpage_image] =>[orig_patent_app_number] => 539292
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/539292 | Preparation of glucosaminyl muramic acid derivatives | Oct 3, 1995 | Issued |
| 08/529889 | CROSS-LINKED BIOBASED MATERIALS AND USES THEREOF | Sep 17, 1995 | Abandoned |
Array
(
[id] => 4317706
[patent_doc_number] => 06248566
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Glucan having cyclic structure and method for producing the same'
[patent_app_type] => 1
[patent_app_number] => 8/528026
[patent_app_country] => US
[patent_app_date] => 1995-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 16055
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248566.pdf
[firstpage_image] =>[orig_patent_app_number] => 528026
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/528026 | Glucan having cyclic structure and method for producing the same | Sep 12, 1995 | Issued |
Array
(
[id] => 3698127
[patent_doc_number] => 05677287
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Antibacterial 16-membered ring macrolides containing olefins at C-20'
[patent_app_type] => 1
[patent_app_number] => 8/513808
[patent_app_country] => US
[patent_app_date] => 1995-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5939
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677287.pdf
[firstpage_image] =>[orig_patent_app_number] => 513808
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/513808 | Antibacterial 16-membered ring macrolides containing olefins at C-20 | Sep 10, 1995 | Issued |
Array
(
[id] => 3726008
[patent_doc_number] => 05681938
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Method for preparing slightly colored alkylpolysaccharides having a low acid breakdown product content'
[patent_app_type] => 1
[patent_app_number] => 8/513843
[patent_app_country] => US
[patent_app_date] => 1995-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2947
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681938.pdf
[firstpage_image] =>[orig_patent_app_number] => 513843
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/513843 | Method for preparing slightly colored alkylpolysaccharides having a low acid breakdown product content | Sep 10, 1995 | Issued |
Array
(
[id] => 3695372
[patent_doc_number] => 05618795
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof'
[patent_app_type] => 1
[patent_app_number] => 8/524644
[patent_app_country] => US
[patent_app_date] => 1995-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14064
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618795.pdf
[firstpage_image] =>[orig_patent_app_number] => 524644
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/524644 | Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof | Sep 7, 1995 | Issued |
Array
(
[id] => 3663062
[patent_doc_number] => 05648475
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Process for preparing alkyl glycosides having a low degree of glycosidation'
[patent_app_type] => 1
[patent_app_number] => 8/524530
[patent_app_country] => US
[patent_app_date] => 1995-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1666
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648475.pdf
[firstpage_image] =>[orig_patent_app_number] => 524530
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/524530 | Process for preparing alkyl glycosides having a low degree of glycosidation | Sep 6, 1995 | Issued |
| 08/520591 | MODULATION OF CELLULAR ACTIVITY | Aug 29, 1995 | Abandoned |
Array
(
[id] => 3696369
[patent_doc_number] => 05595976
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-21
[patent_title] => 'Tetrahydropyran compounds'
[patent_app_type] => 1
[patent_app_number] => 8/521189
[patent_app_country] => US
[patent_app_date] => 1995-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18134
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 709
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/595/05595976.pdf
[firstpage_image] =>[orig_patent_app_number] => 521189
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/521189 | Tetrahydropyran compounds | Aug 29, 1995 | Issued |
Array
(
[id] => 3824892
[patent_doc_number] => 05731259
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Cationic polysaccharides'
[patent_app_type] => 1
[patent_app_number] => 8/520918
[patent_app_country] => US
[patent_app_date] => 1995-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4846
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/731/05731259.pdf
[firstpage_image] =>[orig_patent_app_number] => 520918
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/520918 | Cationic polysaccharides | Aug 28, 1995 | Issued |
Array
(
[id] => 3695258
[patent_doc_number] => 05650433
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Chondroprotective agents'
[patent_app_type] => 1
[patent_app_number] => 8/519179
[patent_app_country] => US
[patent_app_date] => 1995-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3288
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650433.pdf
[firstpage_image] =>[orig_patent_app_number] => 519179
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/519179 | Chondroprotective agents | Aug 24, 1995 | Issued |
Array
(
[id] => 3850962
[patent_doc_number] => 05767108
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Method for making improved heparinized biomaterials'
[patent_app_type] => 1
[patent_app_number] => 8/518147
[patent_app_country] => US
[patent_app_date] => 1995-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4365
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767108.pdf
[firstpage_image] =>[orig_patent_app_number] => 518147
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/518147 | Method for making improved heparinized biomaterials | Aug 21, 1995 | Issued |
Array
(
[id] => 3775240
[patent_doc_number] => 05817642
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Clearing of atherosclerosis'
[patent_app_type] => 1
[patent_app_number] => 8/464769
[patent_app_country] => US
[patent_app_date] => 1995-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2756
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817642.pdf
[firstpage_image] =>[orig_patent_app_number] => 464769
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464769 | Clearing of atherosclerosis | Aug 14, 1995 | Issued |
Array
(
[id] => 3733252
[patent_doc_number] => 05693772
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Desalaninebenanomicin A derivatives and processes for the preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 8/492007
[patent_app_country] => US
[patent_app_date] => 1995-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7148
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693772.pdf
[firstpage_image] =>[orig_patent_app_number] => 492007
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/492007 | Desalaninebenanomicin A derivatives and processes for the preparation thereof | Aug 14, 1995 | Issued |
Array
(
[id] => 3978439
[patent_doc_number] => 05861048
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Phosphorylated saccharide and method for producing the same'
[patent_app_type] => 1
[patent_app_number] => 8/514478
[patent_app_country] => US
[patent_app_date] => 1995-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 18703
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861048.pdf
[firstpage_image] =>[orig_patent_app_number] => 514478
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/514478 | Phosphorylated saccharide and method for producing the same | Aug 10, 1995 | Issued |